EuroAPI saw no growth in patent filings and highest growth of 1.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 1.99%. GlobalData’s DataBook provides a comprehensive analysis of EuroAPI’s patent filings and grants. Buy the databook here.
EuroAPI has been focused on protecting inventions in United States(US) with two publications in Q2 2024
The United States(US) Patent Office dominates the patent grants with nearly 67% of grants. The United States(US), European Patent Office(EPO), and Spain(ES) patent Office are among the top ten patent offices where EuroAPI is filings its patents. Among the top granted patent authorities, EuroAPI has 67% of its grants in United States(US) and 33% in Spain(ES).
Eli Lilly and Co could be the strongest competitor for EuroAPI
Patents related to genomics and cybersecurity lead EuroAPI's portfolio
EuroAPI has the highest number of patents in genomics followed by, cybersecurity and digitalization. For genomics no patents were filed and 33% of patents were granted in Q2 2024.
Refining related patents lead EuroAPI portfolio followed by security services, and data & database management
EuroAPI has highest number of patents in refining followed by security services, data & database management, databases, and endpoint security.
For comprehensive analysis of EuroAPI's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.